Samuel L Jackson blames "cruel" Alzheimer's for ravaging his family

by



[ad_1]

Samuel L Jackson accuses the "cruel" Alzheimer's of ravaging his family while admitting he lost SIX parents to the degenerative disease

By Andrew Bullock for Mailonline

Published on: 00:04 BST, September 16, 2019 | Update: 0:10 BST, September 16, 2019

Samuel L Jackson said that Alzheimer's disease had ravaged his family.

The Hollywood star supports a campaign to combat the misconception that dementia is a fatality of old age. He reacted by taking an example from his own personal experience.

The 70-year-old Jurassic Park actor called for help to end the "cruel condition" with which he saw six of his loved ones live.

The good fight: Samuel L Jackson claimed that Alzheimer's disease had ravaged his family

The good fight: Samuel L Jackson claimed that Alzheimer's disease had ravaged his family

His mother, grandfather, aunts and uncles were diagnosed with the form of dementia, making him a stranger.

As part of the #ShareTheOrange campaign of Alzheimer's Research UK, which aims to get people to think differently about dementia, he said: "I've been surrounded by the disease Alzheimer's most of my life.

"My grandfather was my best friend who grew up in my childhood. It was so heartbreaking to see him not knowing who I was.

"The same thing happened with my mother shortly after the diagnosis. His mother had it, his brother had it, his sister had it, and my aunt on my father's side.

False idea: the Hollywood star supports a campaign to combat the idea that dementia is a fatality of old age. She reacted by taking an example from her own personal experience.

False idea: the Hollywood star supports a campaign to combat the idea that dementia is a fatality of old age. She reacted by taking an example from her own personal experience.

"It's so cruel to have someone who has nurtured and cared for you until you reach a point where you can not even remember." your name. & # 39;

Alzheimer's Research UK uses the symbol of an orange in its campaign to symbolize the weight of the material lost in the brain as the disease develops.

In a new short film produced by Aardman Animations, Jackson states: "The damage done to a brain with Alzheimer's disease can leave it weighing 140g less than a healthy brain. . It's about the weight of an orange … it shows us that it's a physical illness.

Jackson and the charity hope to show the public that Alzheimer's disease is not an inevitable part of aging, but a disease that can be curbed and potentially healed.

As part of the #ShareTheOrange campaign of Alzheimer's Research UK, which aims to get people to think differently about dementia, he said: "I've been surrounded by the disease of Alzheimer's almost all my life "

As part of the #ShareTheOrange campaign of Alzheimer's Research UK, which aims to get people to think differently about dementia, he said: "I've been surrounded by the disease of Alzheimer's almost all my life "

He continued: "Through research, we know that diseases can be slowed, they can be stopped."

The star of Pulp Fiction and Unbreakable follows Bryan Cranston and Christopher Eccleston, who both supported the campaign launched by the charity in 2016.

Hilary Evans, Executive Director of Alzheimer's Research UK, said: "Alzheimer's Research UK relies almost entirely on public donations to support its work, and the ## 147 ## The misconception that dementia is a fatality hinders our ability to recruit volunteers for research, to obtain funding and to lobby. additional government support for research.

"We call the public to #ShareTheOrange, turn fatalism into hope and make dementia the next big medical success."

WAR ON ALZHEIMER: OVER 150 CHESS TRIALS IN 20 YEARS

Scientists have been striving for years to find a way to treat or prevent Alzheimer's disease, which accounts for about two-thirds of the world's 50 million dementia patients.

But attempts to tackle the disease that destroys the brain have been marked by failures.

In March of this year, pharmaceutical company Biogen abandoned two advanced-phase trials of a promising drug against Alzheimer's, aducanumab, which, he hoped, would work by eliminating sticky accumulations in the brain.

After years of research and testing, the company decided that its outlook was mediocre in the final stages of a human trial and has set the course, thus erasing $ 18 billion (£ 13.8 billion) from its market value.

In January, Roche announced the discontinuation of two trials, which were in their third phase of human testing.

He was trying to develop crenezumab, which worked by preventing the accumulation of plaques in the brain and which had already been proven, but did not give the expected results.

Between 1998 and 2017, about 146 drug development attempts against Alzheimer's disease have failed, according to BioSpace's scientific information website.

Billions of dollars have been invested in the industry and an efficient and marketable treatment would probably make a fortune for the company, which gets there first.

Experts said that a difficulty in testing drugs on the right people may be partly to blame – Alzheimer's disease is rarely diagnosed before it is diagnosed and at that time it is often too late or studying people becomes too difficult.

For drugs that attempt to alter the course of a disease, trials often need to be longer and more thorough, which makes them more difficult and expensive, wrote researchers in the journal Expert Opinion on Investigational Drugs.

The same researchers added that scientists may have trouble finding the right dose of medication that could work and that they might recruit the wrong type of people to test them.

[ad_2]

Source link